Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

0.89
Delayed Data
As of 2:51pm ET
 0.00 / 0.00%
Today’s Change
0.70
Today|||52-Week Range
2.44
-39.25%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close0.89
Today’s open0.85
Day’s range0.85 - 0.89
Volume15,281
Average volume (3 months)42,415
Market cap$17.2M
Dividend yield--
Data as of 2:51pm ET, 06/26/2017

Growth & Valuation

Earnings growth (last year)+17.60%
Earnings growth (this year)+6.02%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.64

Competitors

 Today’s
change
Today’s
% change
CYCCCyclacel Pharmaceuti...+0.03+0.73%
EPIXESSA Pharma Inc-0.00-0.50%
ARGSArgos Therapeutics I...-0.01-2.92%
ACSTAcasti Pharma Inc+0.02+1.64%
Data as of 3:19pm ET, 06/26/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
James Garner
Chief Business Officer
Peng Leong
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts